Celcuity (CELC) Interest Coverage Ratio (2017 - 2026)
Celcuity's (CELC) quarterly Interest Coverage Ratio came in at 16.81 in Q4 2025, down 51.11% YoY from 34.38 in Q4 2024, and down 7157.54% on a QoQ basis from 0.23 in Q3 2025.
Celcuity (CELC) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Celcuity (CELC) has 9 years of Interest Coverage Ratio data on file, last reported at 16.81 in Q4 2025.
- Quarterly Interest Coverage Ratio fell 51.11% year-over-year to 16.81 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 22.98 (up 9.99% YoY) and the FY2025 annual result came in at 0.37, up 80.45% from the prior year.
- Interest Coverage Ratio declined to 16.81 in Q4 2025, from 0.23 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 48.71 in Q4 2021 to a low of 27.51 in Q4 2022.
- A 5-year average of 2.82 and a median of 1.61 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio soared 100.05% — and 2025, when it plunged 812.89%.
- Tracing CELC's Interest Coverage Ratio over 5 years: stood at 48.71 in 2021, then tumbled by 156.47% to 27.51 in 2022, then increased by 17.43% to 22.71 in 2023, then jumped by 51.03% to 11.12 in 2024, then slumped by 51.11% to 16.81 in 2025.
- The last three Interest Coverage Ratio figures came in at 16.81 (Q4 2025), 0.23 (Q3 2025), and 2.47 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | -0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.14 |
| Dec 31, 2025 | -16.81 |
| Sep 30, 2025 | -0.23 |
| Jun 30, 2025 | -2.47 |
| Mar 31, 2025 | -5.20 |
| Dec 31, 2024 | -11.12 |
| Sep 30, 2024 | -1.61 |
| Jun 30, 2024 | -1.03 |
| Mar 31, 2024 | -0.57 |
| Dec 31, 2023 | -22.71 |
| Sep 30, 2023 | -3.53 |
| Jun 30, 2023 | -1.67 |
| Mar 31, 2023 | -1.61 |
| Dec 31, 2022 | -27.51 |
| Sep 30, 2022 | -1.37 |
| Jun 30, 2022 | -1.56 |
| Mar 31, 2022 | -3.73 |
| Dec 31, 2021 | 48.71 |
| Sep 30, 2021 | -0.76 |
| Jun 30, 2021 | -1.13 |